Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Atlas, CMEA Test New Biotech Model

Apr 01 2011

• By Alex Lash

Related Content

Two's a Crowd: Versartis Raises $21 Million Series B, Cleaves Off Diabetes Asset to Form Diartis Pharma

Feb 16 2011

Back To The Drawing Board For Portola After Merck Returns Betrixaban

Mar 24 2011

Unnamed Lilly "Mirror Fund" Acquires First Two Compounds

Feb 15 2011

With Pharma Ready to Pare Portfolios, Project Financing Funds Make Their Pitches

Jun 01 2010

PanGenetics' NGF Antibody Sale Illustrates Index's Asset-Focused Strategy

Dec 01 2009

Corporate VC Adds a Business Development Flavor

Nov 01 2007

Lilly's Evolving Corporate Venture Model

Oct 01 2010

Related Companies

Portola Pharmaceuticals, Inc.

Eli Lilly and Company

Abbott

Additional Topics

Strategy Business Strategies

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window